Search results
Results from the WOW.Com Content Network
Tolerability, however, is often relative to the severity of the medical condition a drug is designed to treat. [1] For instance, cancer patients may tolerate significant pain or discomfort during a chemotherapeutic study with the hope of prolonging survival or finding a cure, whereas patients experiencing a benign condition, such as a headache ...
Drug tolerance or drug insensitivity is a pharmacological concept describing subjects' reduced reaction to a drug following its repeated use. Increasing its dosage may re-amplify the drug's effects; however, this may accelerate tolerance, further reducing the drug's effects.
The Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. 91–513, 84 Stat. 1236, enacted October 27, 1970, is a United States federal law that, with subsequent modifications, requires the pharmaceutical industry to maintain physical security and strict record keeping for certain types of drugs. [1]
The ban will see 15 dangerous opioids and five other drugs become Class A drugs under the Misuse of Drugs Act 1971. (Getty Images/iStockphoto) Twenty dangerous opioids and drugs will be banned in ...
Local laws began prohibiting certain types of drugs in 1875. The first federal restriction on drugs was passed in 1909, banning the importation of opium. The Harrison Narcotics Tax Act was passed in 1914 to regulate the sale of narcotics in compliance with the International Opium Convention. This regulation effectively criminalized opium ...
They speculate that younger generations of women engaging in the now de-feminized act of opiate use may view it as an act of empowerment or rebellion against traditional images of femininity. [ 9 ] Charles E. Reasons said that The Legislation of Morality presented "myths concerning the nature and effects of drugs" without systematic ...
The Anti-Drug Abuse Act of 1988 (Pub. L. 100–690, 102 Stat. 4181, enacted November 18, 1988, H.R. 5210) is a major law of the War on Drugs passed by the U.S. Congress which did several significant things:
On Monday, Axsome Therapeutics, Inc. (NASDAQ:AXSM) released data from ACCORD-2, ADVANCE-2, and long-term safety trials AXS-05 (dextromethorphan-bupropion) in Alzheimer's disease agitation. The ...